Søren Carlsen

Søren Carlsen is the Managing Partner in Novo Ventures and Novo Seeds, Novo A/S.

Søren Carlsen joined Novo Nordisk A/S as a research scientist in 1979. He was appointed Vice President of Biotechnology in 1986. In 1991, Søren moved to Davis, California, to establish Novozymes Biotech, Inc., which is a research based company focusing on the development of enzymes and other bio-industrial products. In 1994, Søren was appointed head of Novo Nordisk's Enzyme business as Corporate Vice President and Chief Science Officer. In this function he was responsible for 400 scientists in Denmark, USA, Japan and China.

In 2000, Søren moved to his present position in Novo A/S to establish Novo’s new venture activities. He is a member of the board of directors of 7TM Pharma A/S, PTC Therapeutics, Inc. and Santaris Pharma A/S, and was a board member of Arpida Ltd.

Since 1995, Søren has been chairman of Danish Biotech (the Association of Biotechnology Industries in Denmark). He was granted the Danish Chemistry Prize in 1988.